Ingrid Teige
10Patents
2h-index
16Co-inventors
43Inventor score
Filing activity: Dec 10, 2010 → Nov 14, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9150647B2 | Biological inhibitors of ROR1 capable of inducing cell death | Chemistry; Metallurgy | 27 | Active |
| US9266952B2 | Antibodies against ROR1 and uses thereof | Chemistry; Metallurgy | 22 | Active |
| US10525129B2 | Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies | Human Necessities | 1 | Active |
| US12139547B2 | Agonistic anti TNFR2 antibody molecules | Chemistry; Metallurgy | 0 | Active |
| US9803013B2 | Biological materials and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12344673B2 | Medicaments, uses and methods | Chemistry; Metallurgy | 0 | Active |
| US12371498B2 | Combination and use of antibodies | Chemistry; Metallurgy | 0 | Active |
| US12291569B2 | Antibodies and nucleotide sequences, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11623005B2 | Combined use of FcγRIIb (CD32B) and CD20 specific antibodies | Human Necessities | 0 | Active |
| US11447549B2 | Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.